Shenzhen Hepalink Pharmaceutical Group (SHEZF) News Today $0.47 0.00 (0.00%) As of 06/20/2025 Add Compare Share Share Headlines Stock AnalysisChartBuy This Stock SHEZF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Shenzhen Hepalink’s Ivenoxin Gains Approval for South African MarketApril 24, 2025 | tipranks.comShenzhen Hepalink Releases 2025 Q1 Financial ReportApril 24, 2025 | tipranks.comShenzhen Hepalink Schedules Board Meeting for Q1 ResultsApril 10, 2025 | tipranks.comShenzhen Hepalink Receives Approval for Clinical Trial of New Cancer DrugFebruary 18, 2025 | tipranks.comShenzhen Hepalink Strengthens European Market Position with EMA GMP CertificationFebruary 14, 2025 | tipranks.comHepalink Partners with Yongtai for U.S. Gabapentin MarketJanuary 2, 2025 | tipranks.comShenzhen Hepalink Pharmaceutical Group Co. Ltd. AOctober 13, 2023 | wsj.comOncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate OregovomabOctober 6, 2023 | finance.yahoo.com Get Shenzhen Hepalink Pharmaceutical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHEZF and its competitors with MarketBeat's FREE daily newsletter. Email Address SHEZF Media Mentions By Week SHEZF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHEZF News Sentiment▼0.000.67▲Average Medical News Sentiment SHEZF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHEZF Articles This Week▼00▲SHEZF Articles Average Week Get Shenzhen Hepalink Pharmaceutical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHEZF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 1933 Industries News 4Front Ventures News AB Science News Almirall News Amazonas Florestal News American Green News Avant Brands News Avicanna News BioSyent News Cannabis Global News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHEZF) was last updated on 6/22/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shenzhen Hepalink Pharmaceutical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
